Patanjali claims success in Covid cure

Published On 2020-06-14 05:45 GMT   |   Update On 2020-06-14 09:25 GMT

New Delhi: Yoga guru Ramdev-run Patanjali Ayurved has claimed that it has discovered substantial cure for coronavirus with 80 per cent success rate as per reports. CEO of Patanjali Ayurved Acharya Balkrishna said the company will share the results of clinical trial soon, and that the patients treated by the said medicine have tested negative. The company is conducting clinical trials as...

Login or Register to read the full article

New Delhi: Yoga guru Ramdev-run Patanjali Ayurved has claimed that it has discovered substantial cure for coronavirus with 80 per cent success rate as per reports.

CEO of Patanjali Ayurved Acharya Balkrishna said the company will share the results of clinical trial soon, and that the patients treated by the said medicine have tested negative.

The company is conducting clinical trials as per government regulations.

The Health Ministry on Saturday stated that during the last 24 hours, a total of 7,135 COVID-19 patients have been cured. Thus, so far, a total of 1,54,329 patients have been cured of COVID-19.

The recovery rate is 49.95 per cent among COVID-19 patients. At present, there are 1,45,779 active cases in the country and all are under active medical supervision.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Disclaimer :- This story, apart from the heading, has not been edited by Medical Dialogues Team and is auto-generated from news agency feeds. Source: IANS

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News